AZN vs CTMX · P/E 28, $288.38B cap vs rev $11.7M
AstraZeneca PLC (AZN) versus CytomX Therapeutics Inc (CTMX) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
CytomX Therapeutics Inc (CTMX) is a biotechnology company listed on US.
AZN does not have a complete income-statement cache yet.
Latest reported CTMX revenue for 2026-06-30 was $11.7M. Net income was -$38.9M. Revenue was up 13.8% from 2026-03-31 to 2026-06-30. CTMX currently screens at market cap $653.1M.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. CTMX currently screens at market cap $653.1M.
Not investment advice. Open the AZN and CTMX stock pages for the full models.
Not investment advice.